Aurisco Pharmaceutical Co.,Ltd.

Aurisco Pharmaceutical Co.,Ltd. - PE Ratioverified

605116.SS

Price:

$19.35

Market Cap:

$7.86B

Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid prepara...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2020-09-21

Stock Exchange

SHH

Ticker

605116.SS

The PE Ratio as of July 2026 (TTM) for Aurisco Pharmaceutical Co.,Ltd. (605116.SS) is 22.42

According to Aurisco Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 22.42. This represents a change of -19.31% compared to the average of 27.79 of the last 4 quarters.

Aurisco Pharmaceutical Co.,Ltd. (605116.SS) Historical PE Ratio (quarterly & annually)

How has 605116.SS PE Ratio performed in the past?

The mean historical PE Ratio of Aurisco Pharmaceutical Co.,Ltd. over the last ten years is 38.32. The current 22.42 PE Ratio has changed 5.75% with respect to the historical average. Over the past ten years (40 quarters), 605116.SS's PE Ratio was at its highest in in the December 2022 quarter at 102.36. The PE Ratio was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

38.32

Median

34.21

Minimum

7.35

Maximum

100.42

Aurisco Pharmaceutical Co.,Ltd. (605116.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aurisco Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.27%

Maximum Annual PE Ratio = 100.42

Minimum Annual Increase = -68.42%

Minimum Annual PE Ratio = 7.35

Quarterly (TTM)
Annual
YearPE RatioChange
202522.37-5.75%
202423.73-35.37%
202336.72-22.67%
202247.48-9.44%
202152.4338.75%
202037.7963.06%
201923.17-26.92%
201831.71-68.42%
2017100.421.27%

Aurisco Pharmaceutical Co.,Ltd. (605116.SS) Average PE Ratio

How has 605116.SS PE Ratio performed in the past?

The current PE Ratio of Aurisco Pharmaceutical Co.,Ltd. (605116.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

27.60

5-year avg

36.54

10-year avg

38.32

Aurisco Pharmaceutical Co.,Ltd. (605116.SS) PE Ratio vs. Peers

How is 605116.SS’s PE Ratio compared to its peers?

Aurisco Pharmaceutical Co.,Ltd.’s PE Ratio is less than Shanghai Haohai Biological Technology Co., Ltd. (31.47), less than Chengdu Kanghua Biological Products Co., Ltd. (25.89), greater than Guilin Sanjin Pharmaceutical Co., Ltd. (17.05), less than Chengdu Easton Biopharmaceuticals Co., Ltd. (34.11), less than Chengzhi Shareholding Co., Ltd. (158.19), greater than Daan Gene Co., Ltd. (-8.00), greater than Hunan Jiudian Pharmaceutical Co., Ltd. (13.57), less than Anhui Huaheng Biotechnology Co., Ltd. (31.96), less than Zhejiang Ausun Pharmaceutical Co., Ltd. (58.66), less than Chengdu Olymvax Biopharmaceuticals Inc. (192.84),

Build a custom stock screener for Aurisco Pharmaceutical Co.,Ltd. (605116.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurisco Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aurisco Pharmaceutical Co.,Ltd. (605116.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aurisco Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Aurisco Pharmaceutical Co.,Ltd.'s PE Ratio?

How is the PE Ratio calculated for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?

What is the highest PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?

What is the 3-year average PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?

What is the 5-year average PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?

How does the current PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS) compare to its historical average?